Genemed Biotechnologies
Genemed Biotechnologies is a private US specialty biotechnology company that develops and manufactures immunohistochemistry antibodies, ISH probes, recombinant proteins, and molecular diagnostics components, selling direct to clinical labs and as OEM supply to other IVD manufacturers.
- Company typePrivate
- Founded1987
- HeadquartersTorrance, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Genemed Biotechnologies does
Genemed Biotechnologies is a privately held US specialty biotechnology company founded in 1987, operating in tissue-based diagnostics and molecular diagnostics reagents. Its core product portfolio centers on immunohistochemistry (IHC) and in-situ hybridization (ISH) — including rabbit and mouse monoclonal primary antibodies, polymer-based detection systems (Power-Stain), and chromogenic (CISH) and fluorescent (FISH) probes for detecting gene amplification, deletion, translocations, and chromosome copy number changes in formalin-fixed, paraffin-embedded tissue. The company also markets functional mammalian-expressed recombinant human proteins spanning 13 signaling pathways, DNA/RNA sample extraction kits using biocookie pipette-tip technology distributed with BioSample, and a digital multiplex platform branded DigiPlex for simultaneous multi-target molecular and proteomic assays.
The company's business model combines catalog reagent sales and contract manufacturing services. It sells IHC/ISH reagents, recombinant proteins, and molecular diagnostics components directly to clinical laboratories, hospital pathology labs, pharmaceutical and biotech companies, academic researchers, and molecular diagnostics developers, with same-day fulfillment for orders placed before 1 PM PST shipped Federal Express overnight under net-30 terms. In parallel, Genemed operates an OEM/bulk manufacturing business supplying reagents to other IVD manufacturers, including formulation, filling, labeling, packaging, process validation, and 510K submission support. International reach is achieved through a distributor network, and the company carries ISO certification, CE IVD marking, and FDA IVD labeling. The company maintains the sub-brands DigiPlex (multiplex platform) and Power-Stain (detection system).
Genemed Biotechnologies firmographics
Firmographics- Name
- Genemed Biotechnologies
- Legal name
- Genemed
- Website
- https://genemed.com
- Company type
- Private
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Genemed Biotechnologies is a private US specialty biotechnology company that develops and manufactures immunohistochemistry antibodies, ISH probes, recombinant proteins, and molecular diagnostics components, selling direct to clinical labs and as OEM supply to other IVD manufacturers.
- Ownership category
- akta.pro rank
Genemed Biotechnologies industry classification
Industry- Product category
- In-vitro diagnostics reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)
- akta.pro secondary industries
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Anatomic Pathology & Histology/Cytology IVD (Tissue Diagnostics) (HLAHAAAE)
Keywords
Where Genemed Biotechnologies is headquartered
LocationHeadquarters
- HQ city
- Torrance
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Genemed Biotechnologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- IVD Reagent and Antibody Product Sales: Sale of immunohistochemistry products including primary antibodies (mouse monoclonal and rabbit monoclonal), detection systems, and ancillary reagents for in-vitro diagnostic use
- ISH Product Sales: Sale of in-situ hybridization products including CISH probes, FISH probes, and ancillary reagents for detecting genetic aberrations
- Recombinant Protein Sales: Sale of functional recombinant human proteins for research and drug discovery applications across multiple signaling pathways
- Contract Manufacturing Services: OEM/bulk manufacturing services for IHC/ISH reagents, molecular IVD reagents, and PCR components including formulation, filling, labeling, packaging, and 510K submission support
- Custom Development Services: Custom monoclonal antibody development through B-cell cloning, custom full-length protein production, and IHC/ISH assay development and validation services
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Standard product catalog pricing for IVD reagents and antibodies |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Genemed Biotechnologies product offering
Product offeringCore offering
Genemed Biotechnologies manufactures and sells in-vitro diagnostic (IVD) reagents for tissue-based diagnostics, including immunohistochemistry (IHC) primary antibodies, polymer detection systems, chromogenic and fluorescent in-situ hybridization (CISH/FISH) probes, mammalian-expressed recombinant human proteins, and DNA/RNA sample extraction kits. The company also provides contract manufacturing (OEM/bulk) and custom development services for IVD reagents, including formulation, filling, validation, and 510K submission support.
Product overview
Genemed Biotechnologies offers a comprehensive portfolio of tissue-based diagnostics products and IVD reagent manufacturing services. The product portfolio centers on three core product lines: (1) Immunohistochemistry (IHC) products including primary antibodies and detection systems; (2) In-Situ Hybridization (ISH) products including CISH and FISH probes for genetic aberration detection; and (3) Functional Recombinant Human Proteins for research applications. The company also provides molecular diagnostics components (DNA/RNA extraction kits and PCR controls) and a digital multiplex solutions platform. These products are complemented by extensive contract manufacturing and development services for IVD reagents, including IHC/ISH development and manufacturing, PCR component manufacturing, and custom recombinant protein and monoclonal antibody production services using B-cell cloning technology.
Differentiator
Problem solved
Functional benefit
Brands
- DigiPlex: Digital multiplex platform for molecular and proteomic assays, referenced in AACR 2014 poster presentation on KRAS, BRAF, and EGFR mutational analysis
- Power-Stain
Products and services
- Immunohistochemistry (IHC) Products
Quantifiable outcome
- Better results and higher dilutions compared to other suppliers on automated systems (per customer testimonial)
Companies that use Genemed Biotechnologies
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles4 records
Genemed Biotechnologies technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Genemed Biotechnologies partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- ISO (International Organization for Standardization)coreGenemed maintains ISO certification for quality management. The ISO logo is displayed on the website footer linking to iso.org, indicating compliance with international quality standards.
- CE Marking / European UnioncoreGenemed products carry CE IVD marking for European market access, indicated in product pages stating 'USA IVD, CE IVD' intended use. Links to European Union enterprise policies for single market goods and CE marking.
- UL (Underwriters Laboratories)minorUL certification referenced in the website for ISO certificate. The UL link in the site navigation connects to their ISO certificate PDF, indicating third-party quality certification.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Genemed Biotechnologies competitors and assessment
Company assessmentDirect peers
- Cell Signaling Technology: Specialized manufacturer of high-quality antibodies and recombinant proteins for signaling pathway research and IHC. Directly comparable product portfolio covering the same rabbit monoclonal and recombinant protein categories that Genemed sells.
- Abcam: Global antibody reagent supplier with a deep catalog of primary antibodies and assay kits used in IHC, Western blot, and flow cytometry. Comparable target customers (academic and pharma research labs) and product category.
- Novus Biologicals (Bio-Techne): Antibody and reagent supplier serving life science researchers with primary antibodies, recombinant proteins, and assay kits. Directly comparable catalog offering and customer base.
- Santa Cruz Biotechnology: Supplier of research antibodies including monoclonal and polyclonal antibodies for IHC and related applications. Comparable product line and academic/biopharma customer overlap.
- Atlas Antibodies: Developer of highly validated antibodies for IHC and tissue-based research, including the Human Protein Atlas initiative. Directly comparable in IHC-validated antibody focus and pathology customer base.
Broad incumbents
- Dako (Agilent Technologies): Established leader in IHC reagents, antibodies, and companion diagnostic assays, now part of Agilent. Larger incumbent operating in Genemed's exact IHC/ISH space but with broader portfolio and global scale.
- Leica Biosystems (Danaher): Major pathology solutions provider offering IHC/ISH reagents, instruments, and workflows. Directly overlapping with Genemed's tissue-based diagnostics business but with integrated instruments and global reach.
- Bio-Rad Laboratories: Diversified life science company with a significant antibodies, reagents, and IVD consumables portfolio. Comparable as a scaled incumbent serving pathology and molecular diagnostics customers.
- Roche Diagnostics: Global IVD giant with comprehensive pathology reagent, antibody, and companion diagnostic offerings. Represents the scaled end of Genemed's competitive set in tissue-based diagnostics.
- Thermo Fisher Scientific: Diversified life science tools and IVD company offering antibodies, recombinant proteins, and contract manufacturing services through its bioscience and specialty diagnostics segments. Comparable as a broad incumbent in adjacent categories.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Genemed Biotechnologies compliance and trust
Trust signalCompliance3 records
Genemed Biotechnologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Genemed Biotechnologies leadership team
Management profileNumber of profiles
Genemed Biotechnologies funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Genemed Biotechnologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Genemed Biotechnologies
What does Genemed Biotechnologies do?
Genemed Biotechnologies manufactures and sells in-vitro diagnostic (IVD) reagents for tissue-based diagnostics, including immunohistochemistry (IHC) primary antibodies, polymer detection systems, chromogenic and fluorescent in-situ hybridization (CISH/FISH) probes, mammalian-expressed recombinant human proteins, and DNA/RNA sample extraction kits. The company also provides contract manufacturing (OEM/bulk) and custom development services for IVD reagents, including formulation, filling, validation, and 510K submission support.
Is Genemed Biotechnologies a public or private company?
Genemed Biotechnologies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Genemed Biotechnologies founded?
Genemed Biotechnologies was founded in 1987. It employs 11 to 50 people.
Where is Genemed Biotechnologies based?
Genemed Biotechnologies is headquartered in Torrance, United States, in the North America region.
How does Genemed Biotechnologies make money?
Five revenue lines are on record. IVD Reagent and Antibody Product Sales are the primary driver. The others are ISH Product Sales, recombinant Protein Sales, contract Manufacturing Services and custom Development Services.
Who are Genemed Biotechnologies's main competitors?
Direct peers on record are Cell Signaling Technology, Abcam, Novus Biologicals (Bio-Techne), Santa Cruz Biotechnology and Atlas Antibodies. Broad incumbents are Dako (Agilent Technologies), Leica Biosystems (Danaher), Bio-Rad Laboratories, Roche Diagnostics and Thermo Fisher Scientific.
Does Genemed Biotechnologies have an API?
No public API is recorded for Genemed Biotechnologies.
What industry is Genemed Biotechnologies in?
Genemed Biotechnologies's product category is In-vitro diagnostics reagents. Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument), with a secondary code of HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 325413 and its SIC code is 2835.